Home » Newsletters » BioWorld Science

BioWorld Science

April 4, 2008

View Archived Issues

ABT-335 and statin combinations effective in phase III dyslipidemia studies

Heart failure model reveals novel activity of inotropic agent CK-452

Follow-up data support effect of green tea catechins in preventing prostate cancer

Oral AS-606521 inhibits uterine activity in pregnant rhesus monkeys

Takeda joins an initiative to discover biomarkers

PharmaMar's Yondelis granted orphan drug status in Switzerland, EMEA approval for phase III trial

Recent Merck & Co. patent discloses new remedial options for glaucoma

Myostatin-inhibiting gene therapy shows benefit in a mouse model of Duchenne muscular dystrophy

Chronogen patent divulges new treatment alternatives for age-related disorders

Recent Dainippon Sumitomo patent describes novel therapeutic agents for dermatitis

Carfilzomib receives FDA orphan drug designation in multiple myeloma

Eisai to resume E-2012 clinical trial in Alzheimer's disease

New antiatherosclerotic agent reported in recent Merck & Co. patent

BioMarker Pharmaceuticals launches Gene Essence genome analysis test in the U.S.

Monogram enters agreement to provide resistance and tropism testing of Progenics' PRO-140

ISTA reports results from clinical trial of once-daily Xibrom for ocular inflammation

EMEA accepts for review Cell Therapeutics' MAA for Xyotax in NSCLC

U.S. phase III clinical trial of Kamada's intravenous AAT meets primary endpoint

Cosmo begins phase I trials of anti-androgen cream as skin disorder therapy

Meda files for European approval of BioDelivery Sciences' BEMA fentanyl

Teijin enters license agreement in Japan with Dong Wha for DW-1350 in osteoporosis

ProtAffin is awarded EUR 1.1 million research grant in Austria for development of PA-401

EnVivo initiates clinical safety and biomarker study of EVP-6124 in schizophrenia

The FDA accepts FibroGen's complete response for clinical holds of FG-2216 and FG-4592

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...